OBJECTIVE: Butylated hydroxyanisole (BHA) is a synthetic phenolic compound that is a potent inducer of phase II genes. Since heme oxygenase-1 (HO-1) is a vasoprotective protein that is upregulated by phase II inducers, the present study examined the effects of BHA on HO-1 gene expression and vascular smooth muscle cell proliferation. METHODS: The regulation of HO-1 gene expression and vascular cell growth by BHA was studied in cultured rat aortic smooth muscle cells and in balloon injured rat carotid arteries. RESULTS: Treatment of cultured smooth muscle cells with BHA stimulated the expression of HO-1 protein, mRNA and promoter activity in a time- and concentration-dependent manner. BHA-mediated HO-1 expression was dependent on the activation of NF-E2-related factor-2 by p38 mitogen-activated protein kinase. BHA also inhibited cell cycle progression and DNA synthesis in an HO-1-dependent manner. In addition, the local perivascular delivery of BHA immediately after arterial injury of rat carotid arteries induced HO-1 protein expression and markedly attenuated neointima formation. CONCLUSIONS: These studies demonstrate that BHA stimulates HO-1 gene expression in vascular smooth muscle cells, and that the induction of HO-1 contributes to the antiproliferative actions of this phenolic antioxidant. BHA represents a potentially novel therapeutic agent in treating or preventing vasculoproliferative disease.
OBJECTIVE:Butylated hydroxyanisole (BHA) is a synthetic phenolic compound that is a potent inducer of phase II genes. Since heme oxygenase-1 (HO-1) is a vasoprotective protein that is upregulated by phase II inducers, the present study examined the effects of BHA on HO-1 gene expression and vascular smooth muscle cell proliferation. METHODS: The regulation of HO-1 gene expression and vascular cell growth by BHA was studied in cultured rat aortic smooth muscle cells and in balloon injured rat carotid arteries. RESULTS: Treatment of cultured smooth muscle cells with BHA stimulated the expression of HO-1 protein, mRNA and promoter activity in a time- and concentration-dependent manner. BHA-mediated HO-1 expression was dependent on the activation of NF-E2-related factor-2 by p38 mitogen-activated protein kinase. BHA also inhibited cell cycle progression and DNA synthesis in an HO-1-dependent manner. In addition, the local perivascular delivery of BHA immediately after arterial injury of rat carotid arteries induced HO-1 protein expression and markedly attenuated neointima formation. CONCLUSIONS: These studies demonstrate that BHA stimulates HO-1 gene expression in vascular smooth muscle cells, and that the induction of HO-1 contributes to the antiproliferative actions of this phenolic antioxidant. BHA represents a potentially novel therapeutic agent in treating or preventing vasculoproliferative disease.
Authors: L E Otterbein; F H Bach; J Alam; M Soares; H Tao Lu; M Wysk; R J Davis; R A Flavell; A M Choi Journal: Nat Med Date: 2000-04 Impact factor: 53.440
Authors: J Alam; C Wicks; D Stewart; P Gong; C Touchard; S Otterbein; A M Choi; M E Burow; J Tou Journal: J Biol Chem Date: 2000-09-08 Impact factor: 5.157
Authors: Juan F Granada; Diana Ensenat; Amit N Keswani; Grzegorz L Kaluza; Albert E Raizner; Xiao-ming Liu; Kelly J Peyton; Mohammed A Azam; Hong Wang; William Durante Journal: Arterioscler Thromb Vasc Biol Date: 2005-09-01 Impact factor: 8.311
Authors: Y Togane; T Morita; M Suematsu; Y Ishimura; J I Yamazaki; S Katayama Journal: Am J Physiol Heart Circ Physiol Date: 2000-02 Impact factor: 4.733
Authors: H J Duckers; M Boehm; A L True; S F Yet; H San; J L Park; R Clinton Webb; M E Lee; G J Nabel; E G Nabel Journal: Nat Med Date: 2001-06 Impact factor: 53.440
Authors: Xiaoping Yang; D Paul Thomas; Xiaochun Zhang; Bruce W Culver; Brenda M Alexander; William J Murdoch; Mysore N A Rao; David A Tulis; Jun Ren; Nair Sreejayan Journal: Arterioscler Thromb Vasc Biol Date: 2005-10-20 Impact factor: 8.311